Pharmacokinetics and pharmacodynamics of rosuvastatin in subjects with hepatic impairment (Q44334631)

2 December 2017

title

Pharmacokinetics and pharmacodynamics of rosuvastatin in subjects with hepatic impairment (English)

1 reference

2 December 2017

1 reference

1 reference

S G Simonson

1

1 reference

2 December 2017

P D Martin

2

1 reference

2 December 2017

P Mitchell

3

1 reference

2 December 2017

D W Schneck

4

1 reference

2 December 2017

K C Lasseter

5

1 reference

2 December 2017

M J Warwick

6

1 reference

2 December 2017

publication date

30 January 2003

1 reference

European Journal of Clinical Pharmacology

2 December 2017

published in

1 reference

2 December 2017

volume

58

1 reference

2 December 2017

issue

10

1 reference

2 December 2017

page(s)

669-675

1 reference

Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0541-7

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0541-7

No effect of age or gender on the pharmacokinetics of rosuvastatin: a new HMG-CoA reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0541-7

The effect of fluconazole on the pharmacokinetics of rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0541-7

Liver-specific distribution of rosuvastatin in rats: comparison with pravastatin and simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0541-7

A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0541-7

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0541-7

Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0541-7

Quantification of rosuvastatin in human plasma by automated solid-phase extraction using tandem mass spectrometric detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-002-0541-7

Dosing recommendations in liver disease

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12610743

12 December 2020

inferred from PubMed ID database lookup

Corticosteroid therapy of alcoholic hepatitis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12610743

12 December 2020

inferred from PubMed ID database lookup

Lack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjects

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12610743

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00228-002-0541-7

1 reference

release_gxn5o2st2jcg7cs4hyo7o6k2sy

2 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gxn5o2st2jcg7cs4hyo7o6k2sy

24 November 2022

mapped directly with Wikidata item

1 reference